J. Grognux et al. / Tetrahedron: Asymmetry 15 (2004) 2981–2989
2987
34.81, 33.01, 32.54, 30.24, 30.09, 29.96, 29.89, 29.79,
25.57, 23.32, 14.74; IR (film) cmꢀ1: 3566 (b, w), 2927
(s), 2855 (m), 1734 (m), 1610 (s), 1538 (s), 1344 (s),
1288 (s); MS (FAB) m/z: 455 (M+), 437, 425, 271, 183,
109.
69.16, 67.75, 65.17, 34.98, 34.78, 32.61, 31.23, 30.34,
30.18, 30.04, 29.97, 29.82, 25.64, 25.57, 23.37, 14.79;
IR (film) cmꢀ1: 3031 (w), 2925 (s), 2854 (s), 1737 (s),
1609 (s), 1534 (s), 1344 (s), 1288 (s); MS (FAB) m/z:
693 (M+), 663, 607, 509, 465, 284.
Compound 7b: TLC (Hex/EtOAc 1/1) Rf 0.88; 1H NMR
(300MHz, CDCl3) d (ppm): 8.76 (d, 1H), 8.42(dd, 1H),
7.17 (d, 1H), 5.30 (m, 1H), 4.12–4.36 (m, 4H), 2.31 (m,
4H), 2.21 (m, 2H), 1.59 (m, 4H), 1.24 (m, 32H), 0.87
(m, 6H); 13C NMR (75MHz, CDCl3) d (ppm): 174.02,
173.84, 157.02, 140.99, 139.41, 129.72, 122.66, 114.94,
69.14, 67.73, 65.15, 34.95, 34.87, 34.76, 32.57, 31.20,
30.28, 30.15, 30.00, 29.94, 29.89, 29.81, 29.79, 25.61,
25.55, 23.34, 14.76; IR (film) cmꢀ1: 3094 (w), 2927 (s),
2855 (s), 1736 (s), 1609 (s), 1534 (s), 1345 (s), 1287 (s);
MS (FAB) m/z: 636 (M+), 618, 606, 453, 183.
4.14. ( )-(4-(4-Nitrophenyloxy)-2-hydroxybut-1-yl)-hexa-
decanoate 10a and ( )-(4-(4-nitrophenyloxy)-2-hexa-
decanoyloxybut-1-yl)-hexadecanoate 10b
Triethylamine (0.7mL, 4.5mmol) and DMAP (0.0025g,
0.02mmol) are added under N2 to a solution of ( )-4-(4-
nitrophenoxy)-1,2-butanediol 13 (0.500g, 2.2mmol) in
dry DCM (20mL) and DMF (5mL), and the mixture
is cooled to 0ꢁC. Palmitoyl chloride (0.910g, 3.3mmol)
is then added, and the mixture stirred at rt for 18h.
After concentration to dryness the crude product is ta-
ken in EtOAc and water, washed with satd aq NaHCO3,
and brine, dried over MgSO4 and concentrated. The res-
idue is finally purified by flash chromatography on silica
gel (Hex/EtOAc 100/0–50/50) to give compounds 10a
(0.808g, 79%) and 10b (0.032g, 2%).
4.12. ( )-(4-(4-Nitrophenyloxy-2-hydroxybut-1-yl)-tet-
radecanoate 8
The procedure for 2 was applied using tetradecanoyl
chloride (119lL, 0.44mmol). FC gave 8 (126mg,
0.29mmol, 65%) as pale yellow solid, mp 81ꢁC; TLC
Compound 10a: yellow oil; TLC (Hex/EtOAc 50/50, UV
1
1
(Hex/EtOAc 1/1) Rf 0.77; H NMR (300MHz, CDCl3)
254nm): Rf 0.80; H NMR (300MHz, CDCl3) d (ppm):
d (ppm): 8.20 (d, 2H), 6.96 (d, 2H), 4.04–4.29 (m, 5H),
2.36 (t, 2H), 1.98 (m, 2H), 1.64 (m, 2H), 1.25 (m,
20H), 0.88 (t, 3H); 13C NMR (75MHz, CDCl3) ppm:
174.70, 164.42, 142.33, 126.61, 115.13, 69.03, 67.79,
65.85, 34.85, 33.32, 32.58, 30.31, 30.13, 30.01, 29.92,
29.82, 25.61, 23.35, 14.77; IR (film) cmꢀ1: 3506 (b, w),
2926 (s), 2854 (m), 1735 (m), 1594 (m), 1516 (s), 1342
(s), 1263 (s); MS (FAB) m/z: 438 (M+), 421, 299, 284,
211, 124.
8.18 (d, J = 9.2Hz, 2H), 6.95 (d, J = 9.2Hz, 2H), 4.28–
4.03 (m, 5H), 2.37–2.32 (t, J = 7.5Hz, 2H), 2.03–1.93
(m, 2H), 1.65–1.61 (m, 2H), 1.25–1.23 (m, 24H), 0.89–
0.85 (t, J = 6.6Hz, 3H); 13C NMR (75MHz, CDCl3) d
(ppm): 174.7, 164.4, 142.3, 126.6, 115.1, 69.0, 67.7,
65.8, 34.8, 33.3, 32.6, 30.3, 30.2, 30.2, 30.0, 29.9, 29.8,
25.6, 23.3, 14.8; IR (neat) m (cmꢀ1): 3479 (m), 2926 (s),
2855 (s), 1736 (s), 1609 (m), 1595 (s), 1515 (s), 1499
(s), 1468 (m), 1343 (s), 1264 (s), 1174 (s), 1112 (s).
4.13. ( )-(4-(2,4-Dinitrophenyl)-2-hydroxybut-1-yl)-tet-
radecanoate 9a and ( )-(4-(2,4-dinitrophenyl)-2-tetra-
decanoyloxybut-1-yl)-tetradecanoate 9b
Compound 10b: yellow solid, mp 50–51ꢁC; TLC (Hex/
EtOAc 90/10, UV 254nm): Rf 0.38; 1H NMR
(300MHz, CDCl3) d (ppm): 8.19 (d, J = 9.5Hz, 2H),
6.93 (d, J = 9.5Hz, 2H), 5.36–5.31 (m, 1H), 4.32 (dd,
J = 3.7, 12.1Hz, 1H), 4.16–4.08 (m, 3H), 2.33–2.27 (m,
4H), 2.17–2.10 (m, 2H), 1.63–1.57 (m, 4H), 1.25–1.23
(m, 48H), 0.90–0.85 (t, J = 6.6Hz, 6H); 13C NMR
(75MHz, CDCl3) d (ppm): 173.8, 164.2, 145.6, 126.6,
115.1, 69.2, 65.4, 65.3, 35.0, 34.8, 32.6, 31.2, 30.4, 30.2,
30.0, 29.8, 25.7, 25.6, 23.4, 14.8; IR (Chl) m (cmꢀ1):
3025 (w), 2926 (s), 2855 (s), 1741 (s), 1610 (m), 1595
(m), 1518 (m), 1499 (m), 1468 (m), 1343 (s), 1263 (s),
The procedure for 5a/b was applied using diol 14 (60mg,
0.24mmol), triethylamine (100lL, 0.72mmol), DMAP
(1.5mg, 0.01mmol) in CH2Cl2 (4mL). FC gave first 9b
(46mg, 0.07mmol, 27%) as yellow solid, mp 44ꢁC, then
9a (49mg, 0.1mmol, 42%) as yellow solid, mp 53ꢁC.
Compound 9a: TLC (Hex/EtOAc 1/3) Rf 0.82; 1H NMR
(300MHz, CDCl3) d (ppm): 8.78 (d, 1H), 8.45 (dd, 1H),
7.24 (d, 1H), 4.06–4.52 (m, 5H), 2.36 (m, 2H), 2.05 (m,
2H), 1.63 (m, 2H), 1.26 (m, 20H), 0.87 (m, 3H); 13C
NMR (75MHz, CDCl3) ppm: 174.80, 157.29, 140.91,
136.74, 129.88, 122.69, 115.08, 68.89, 68.03, 67.46,
34.82, 33.03, 32.58, 30.34, 30.30, 30.26, 30.11, 30.01,
29.92, 29.82, 25.59, 23.35, 14.76; IR (film) cmꢀ1: 3467
(b, w), 3090 (w), 3026 (w), 2926 (s), 2854 (s), 1732 (s),
1610 (s), 1538 (s), 1345 (s), 1289 (s); MS (FAB) m/z:
465(M++1ꢀOH), 453, 299, 211, 167, 149, 113.
Compound 9b: TLC (Hex/EtOAc 1/3) Rf 0.97; 1H NMR
(300MHz, CDCl3) d (ppm): 8.76 (d, 1H), 8.42(dd, 1H),
7.17 (d, 1H), 5.30 (m, 1H), 4.08–4.36 (m, 4H), 2.31 (m,
4H), 2.19 (m, 2H), 1.58 (m, 4H), 1.25 (m, 40H), 0.88
(m, 6H); 13C NMR (75MHz, CDCl3) d (ppm): 174.05,
173.87, 157.03, 140.44, 139.67, 129.74, 122.70, 114.93,
+
1173 (m), 1112(m) ; EI-MS: 704 [M] .
4.15. ( )-(4-(4-Nitrophenyloxy)-2-hydroxybut-1-yl)-octa-
decanoate 11a and ( )-(4-(4-nitrophenyloxy)-2-octadeca-
noyloxybut-1-yl)-octadecanoate 11b
Triethylamine (1.4mL, 9.5mmol) and DMAP (0.0025g,
0.02mmol) are added under N2 to a solution of ( )-4-(4-
nitrophenoxy)-1,2-butanediol 13 (0.500g, 2.2mmol) in
dry DCM (20mL) and DMF (5mL), and the mixture
is cooled to 0ꢁC. Stearoyl chloride (1g, 3.3mmol) is then
added, and the mixture stirred at rt for 18h. After con-
centration to dryness the crude product is taken in
EtOAc and water, washed with satd aq NaHCO3 and
brine, dried over MgSO4, and concentrated. The residue
is finally purified by flash chromatography on silica gel